DXCM - Rasio utang marang kapitalisasi buku DexCom Inc

Logo korporat perusahaan DexCom, Inc. (DXCM)

The current leverage ratio on the balance sheet provided by the GURU.Markets system is based on the partial outsourcing of sensor production and cloud services, with the parameter equal to 0.50. DexCom, Inc. (DXCM) is striving for global leadership in the CGM segment through expansion into the type 2 diabetes market. Strong operating leverage during the scaling of sensor production ensures sustainable growth in the business's net margin.

DexCom, Inc. - Utang-utang marang kapitalisasi buku DXCM (periode 04.07.2022 - 27.10.2026)
Barang unggulan Dexcom CGM

The selection of defensive assets is based on low credit risk, which for DexCom, Inc. (DXCM) is supported by investments in the digital synergy of glucose sensors with wearable gadgets and pumps. An analysis of the company's total debt-to-equity ratio allows for an assessment of the proportion of liabilities within the equity structure, where a decrease in this metric minimizes default risk but may signal a slowdown in expansion.

Pesaing DexCom, Inc.

PEN: Utang-utang marang kapitalisasi buku|novanta.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Haemonetics (HAE)|INSP - Rasio utang marang aset resik|PRCT: Utang-utang marang kapitalisasi buku|CNMD (CONMED Inc.) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Pulse Biosciences, Inc. PLSE|Rasio utang-utang marang kapitalisasi buku inmodemd.com|Picard Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Surmodics Inc SRDX|Utang marang nilai buku SENS (senseonics.com)|NPCE - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Tactile Systems Technology Inc. TCMD|SNWV - Utang marang modal buku|Outset Medical - Utang-utang marang kapitalisasi buku|Electromed (ELMD) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku LNSR|Utang marang nilai buku AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Utang marang nilai buku|Rasio utang marang aset resik BDMD (bairdmed.com)|EDAP TMS - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku